SomnoMed Investor Presentation April 2024

SomnoMed presents its investment opportunity as the global market leader in oral appliances for obstructive sleep apnea treatment. The company highlights a significant TAM of 900+ million OSA patients and advances in its Rest Assure® technology-enabled oral device. The presentation outlines a $22.6 million capital raise to fund strategic growth initiatives.